VEGFA and age-related macular degeneration: Previous AI studies in nAMD have demonstrated a satisfactory ability to predict the conversion of intermediate-type AMD to nAMD in the same eye and the fellow eye, the recognition of predictive biomarkers for AMD progression, and the study of fluid distribution during anti-VEGF therapy for nAMD [26,27].